By transforming the performance of immunoassays wherever they are utilized within the biopharmaceutical industry, Gyros aims to set an industry standard. The company offers an open immunoassay platform that brings the benefits of miniaturization, integration and automation to the development and production of biotherapeutics, vaccines and immunotherapeutics.
Spanning the spectrum of immunoassay formats, the flexibility of the Gyros platform can be employed from early discovery and development through to preclinical/clinical trails and post-market surveillance. Typical applications include pharmacokinetics, pharmacodynamics, toxicokinetics, biomarker monitoring, immunogenicity, product quantification and impurity testing.
Fast development times, and unattended running of assays at nanoliter scale, save labor, sample and reagents. Time to result is cut significantly and more information can be gained from less sample.